Katalin Sümegi

PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathway

Enikö Hocsák, Viktor Szabó, Nikoletta Kálmán et al. · Free Radical Biology and Medicine · 2017 · 109 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Activation of mitochondrial fusion provides a new treatment for mitochondria-related diseases

Alíz Szabó, Katalin Sümegi, Katalin Fekete et al. · Biochemical Pharmacology · 2018 · 99 citations · Full text

Life Sciences, Cell Biology, Pharmacology +16

BGP-15 Protects against Oxidative Stress- or Lipopolysaccharide-Induced Mitochondrial Destabilization and Reduces Mitochondrial Production of Reactive Oxygen Species

Katalin Sümegi, Katalin Fekete, Csenge Antus et al. · PLoS ONE · 2017 · 61 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

GCKR gene functional variants in type 2 diabetes and metabolic syndrome: do the rare variants associate with increased carotid intima-media thickness?

Márton Mohás, Péter Kisfali, Luca Járomi et al. · Cardiovascular Diabetology · 2010 · 50 citations · Full text

Medicine, Endocrinology, Molecular Genetics +12

Investigation of <i>JAK2</i>, <i>STAT3</i> and <i>CCR6</i> polymorphisms and their gene–gene interactions in inflammatory bowel disease

Noémi Polgár, Veronika Csöngei, Melinda Zsuzsanna Szabó et al. · International Journal of Immunogenetics · 2012 · 34 citations

Life Sciences, Genetics, Immunology +16